Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway

被引：0
|
作者：
He, Ming-ming [1 ]
Xu, Rui-hua [1 ]
Zhang, Dong-sheng [1 ]
Wang, Feng [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15028
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    Ming-ming He
    Dong-sheng Zhang
    Feng Wang
    Zi-xian Wang
    Shu-qiang Yuan
    Zhi-qiang Wang
    Hui-yan Luo
    Chao Ren
    Miao-zhen Qiu
    Ying Jin
    De-shen Wang
    Dong-liang Chen
    Zhao-lei Zeng
    Yu-hong Li
    Yang-yang He
    Yuan-tao Hao
    Pi Guo
    Feng-hua Wang
    Yi-xin Zeng
    Rui-hua Xu
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 69 - 79
  • [2] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    He, Ming-ming
    Zhang, Dong-sheng
    Wang, Feng
    Wang, Zi-xian
    Yuan, Shu-qiang
    Wang, Zhi-qiang
    Luo, Hui-yan
    Ren, Chao
    Qiu, Miao-zhen
    Jin, Ying
    Wang, De-shen
    Chen, Dong-liang
    Zeng, Zhao-lei
    Li, Yu-hong
    He, Yang-yang
    Hao, Yuan-tao
    Guo, Pi
    Wang, Feng-hua
    Zeng, Yi-xin
    Xu, Rui-hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 69 - 79
  • [3] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    Xu, R.
    Zeng, Y.
    He, M. -M.
    Zhang, D.
    Wang, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 61 - 61
  • [4] S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
    Hironaka, Shuichi
    Sugimoto, Naotoshi
    Yamaguchi, Kensei
    Moriwaki, Toshikazu
    Komatsu, Yoshito
    Nishina, Tomohiro
    Tsuji, Akihito
    Nakajima, Takako Eguchi
    Gotoh, Masahiro
    Machida, Nozomu
    Bando, Hideaki
    Esaki, Taito
    Emi, Yasunori
    Sekikawa, Takashi
    Matsumoto, Shigemi
    Takeuchi, Masahiro
    Boku, Narikazu
    Baba, Hideo
    Hyodo, Ichinosuke
    LANCET ONCOLOGY, 2016, 17 (01): : 99 - 108
  • [5] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [6] S-1 with leucovorin and oxaliplatin for advanced gastric cancer
    ter Veer, Emil
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    LANCET ONCOLOGY, 2016, 17 (02): : E41 - E41
  • [7] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
    Koizumi, W.
    Boku, N.
    Yamaguchi, K.
    Miyata, Y.
    Sawaki, A.
    Kato, T.
    Toh, Y.
    Hyodo, I.
    Nishina, T.
    Furuhata, T.
    Miyashita, K.
    Okada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 766 - 771
  • [9] Treatment improvement by addition of leucovorin to S-1 plus oxaliplatin in patients with advanced gastric cancer
    Zaanan, Aziz
    Pernot, Simon
    Taieb, Julien
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S332 - S334
  • [10] A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
    Ueno, M.
    Okusaka, T.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Furukawa, M.
    Iguchi, H.
    Sugimori, K.
    Furuse, J.
    Shimada, K.
    Ioka, T.
    Nakamori, S.
    Baba, H.
    Komatsu, Y.
    Takeuchi, M.
    Hyodo, I.
    Boku, N.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 502 - 508
12345